Publication: 3D-QSAR studies of natural flavonoid compounds as reverse transcriptase inhibitors
Issued Date
2012-05-01
Resource Type
ISSN
15548120
10542523
10542523
Other identifier(s)
2-s2.0-84861882886
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Medicinal Chemistry Research. Vol.21, No.5 (2012), 559-567
Suggested Citation
Narumol Phosrithong, Weerasak Samee, Jiraporn Ungwitayatorn 3D-QSAR studies of natural flavonoid compounds as reverse transcriptase inhibitors. Medicinal Chemistry Research. Vol.21, No.5 (2012), 559-567. doi:10.1007/s00044-011-9570-z Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/13972
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
3D-QSAR studies of natural flavonoid compounds as reverse transcriptase inhibitors
Other Contributor(s)
Abstract
The three-dimensional quantitative structure-activity relationship (3D-QSAR), comparative molecular field analysis (CoMFA), and comparative molecular similarity indices analysis (CoMSIA) were conducted on a series of 44 flavonoid compounds which exhibited in vitro avian myeloblastosis virus-reverse transcriptase (AMVRT) inhibitory activity. The best predictive CoMFA model gives cross-validated r 2 (q 2 ) = 0.665, non-cross-validated r 2 = 0.983, standard error of estimate (S) = 0.047, and F = 357.438. The best CoMSIA model has q 2 = 0.685, non-cross-validated r 2 = 0.963, S = 0.070, and F = 159.764, including steric, electrostatic, hydrogen bond donor, and acceptor fields. The predictive ability of these models was validated by a set of 11 compounds that were not included in the training set. The calculated (predicted) and experimental inhibitory activities were well correlated. Both CoMFA and CoMSIA models suggest fruitful structural insight to design more active compounds. In order to investigate the activity against HIV 1-RT comparing with AMV-RT, the docking simulation of some flavonoids with HIV 1-RT was performed. The flavonoids with good AMV-RT inhibitory activity also showed good binding energies with HIV 1-RT. © Springer Science+Business Media, LLC 2011.